APA

Lynch A. M., Pathak N., Pathak V., O'Harte F. P. M., Flatt P. R., Irwin N. & Gault V. A. (20150330). A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation. : Diabetologia.

Chicago

Lynch Aisling M, Pathak Nupur, Pathak Varun, O'Harte Finbarr P M, Flatt Peter R, Irwin Nigel and Gault Victor A. 20150330. A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation. : Diabetologia.

Harvard

Lynch A. M., Pathak N., Pathak V., O'Harte F. P. M., Flatt P. R., Irwin N. and Gault V. A. (20150330). A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation. : Diabetologia.

MLA

Lynch Aisling M, Pathak Nupur, Pathak Varun, O'Harte Finbarr P M, Flatt Peter R, Irwin Nigel and Gault Victor A. A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation. : Diabetologia. 20150330.